We are live on
!
Find out more
CC
Callan Capital Portfolio holdings
AUM
$1.35B
Turnover
17.35%
1-Year Est. Return
8.35%
This Fund
S&P 500
This Quarter
Est. Return
+6.26%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$864M
AUM Growth
+$54.1M
(+6.7%)
Cap. Flow
+$8.09M
Cap. Flow
% of AUM
0.94%
Top 10 Holdings %
Top 10 Hldgs %
50.84%
Holding
197
New
11
Increased
61
Reduced
63
Closed
13
Avg Time Held
2.5
years
Top 10 Avg Time Held
2.8
years
Top 20 Avg Time Held
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$6.54M |
| 2 |
Schwab International Equity ETF
SCHF
|
+$2.93M |
| 3 |
Schwab Fundamental International Large Company Index ETF
FNDF
|
+$2.51M |
| 4 |
Schwab US Broad Market ETF
SCHB
|
+$1.79M |
| 5 |
Avantis US Small Cap Value ETF
AVUV
|
+$1.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$2.53M |
| 2 |
JPMorgan Ultra-Short Municipal Income ETF
JMST
|
+$2.27M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$1.22M |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$1.1M |
| 5 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$803K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.85% |
| 2 | Technology | 3.67% |
| 3 | Financials | 1.29% |
| 4 | Healthcare | 1.17% |
| 5 | Real Estate | 0.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Schwab US Broad Market ETF
SCHB
$44.9B
| $104M | 12.04% |
6,519,675
+114,345
| +2% | +$1.79M |
2015 Q3
30 quarters
|
|
|
2
Schwab International Equity ETF
SCHF
$67B
| $63.8M | 7.38% |
3,665,832
+170,846
| +5% | +$2.93M |
2015 Q3
30 quarters
|
|
|
3
Schwab Fundamental International Large Company Index ETF
FNDF
$25.5B
| $44.2M | 5.11% |
1,412,810
+81,211
| +6% | +$2.51M |
2016 Q2
27 quarters
|
|
4
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$5.92B
| $39.4M | 4.57% |
1,280,207
-13,827
| -1% | -$421K |
2019 Q3
14 quarters
|
|
|
5
Schwab Fundamental US Large Company Index ETF
FNDX
$28.1B
| $38M | 4.4% |
2,078,370
+356,646
| +21% | +$6.54M |
2019 Q1
16 quarters
|
|
6
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $34.2M | 3.96% |
1,091,590
-9,465
| -0.9% | -$300K |
2013 Q2
39 quarters
|
|
7
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$40.5B
| $31.8M | 3.68% |
989,015
-15,372
| -2% | -$485K |
2021 Q4
5 quarters
|
|
8
Vanguard Tax-Exempt Bond Index Fund
VTEB
$50.4B
| $29.3M | 3.39% |
577,525
-3,464
| -0.6% | -$174K |
2022 Q2
3 quarters
|
|
9
Avantis International Small Cap Value ETF
AVDV
$19.9B
| $28M | 3.24% |
477,997
+20,177
| +4% | +$1.18M |
2021 Q4
5 quarters
|
|
10
iShares International Equity Factor ETF
INTF
$3.69B
| $26.5M | 3.07% |
1,000,009
-29,858
| -3% | -$777K |
2020 Q2
11 quarters
|
|
|
11
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.3B
| $25.9M | 3% |
318,936
-10,125
| -3% | -$803K |
2015 Q4
29 quarters
|
|
12
Schwab Fundamental US Broad Market Index ETF
FNDB
$1.5B
| $25.5M | 2.95% |
1,412,442
-8,937
| -0.6% | -$162K |
2016 Q2
27 quarters
|
|
13
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.2B
| $19.5M | 2.26% |
386,563
-8,127
| -2% | -$401K |
2022 Q1
4 quarters
|
|
14
Vanguard FTSE All-World ex-US ETF
VEU
$67.4B
| $18.1M | 2.09% |
337,902
-1,525
| -0.4% | -$80.8K |
2013 Q2
39 quarters
|
|
15
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $17.6M | 2.04% |
435,136
+17,439
| +4% | +$711K |
2020 Q1
12 quarters
|
|
16
Apple
AAPL
$4.99T
| $16.6M | 1.92% |
100,543
-861
| -0.8% | -$127K |
2017 Q2
23 quarters
|
|
17
State Street Technology Select Sector SPDR ETF
XLK
$125B
| $16.2M | 1.88% |
214,568
-2,442
| -1% | -$168K |
2013 Q2
39 quarters
|
|
18
Schwab Fundamental US Small Company Index ETF
FNDA
$8.78B
| $16.1M | 1.86% |
660,518
+16,636
| +3% | +$415K |
2018 Q3
18 quarters
|
|
19
Vanguard Information Technology ETF
VGT
$150B
| $13.4M | 1.55% |
278,192
+16,016
| +6% | +$708K |
2017 Q1
24 quarters
|
|
20
Avantis US Equity ETF
AVUS
$14.7B
| $12.2M | 1.41% |
171,912
+9,351
| +6% | +$662K |
2022 Q3
2 quarters
|
|
21
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.65B
| $11.2M | 1.3% |
340,180
-1,075
| -0.3% | -$36.2K |
2013 Q2
39 quarters
|
|
22
Dimensional International Small Cap Value ETF
DISV
$5.09B
| $10M | 1.16% |
420,628
-6,400
| -1% | -$152K |
2022 Q2
3 quarters
|
|
23
State Street Health Care Select Sector SPDR ETF
XLV
$45.9B
| $9.31M | 1.08% |
71,882
-2,195
| -3% | -$287K |
2013 Q2
39 quarters
|
|
24
Vanguard Health Care ETF
VHT
$19.9B
| $7.4M | 0.86% |
31,047
+1,319
| +4% | +$317K |
2017 Q1
24 quarters
|
|
25
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.93B
| $6.92M | 0.8% |
157,028
-1,411
| -0.9% | -$62.2K |
2021 Q4
5 quarters
|
|
Similar funds
PRO
MBA
SIA
AP
MW
SBIA
LC
TW
Callan Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Callan Capital held 197 positions worth $864M, up 6.7% from $810M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Callan Capital's Q1 2023 filing shows 11 new, 61 increased, 63 reduced and 13 closed positions. Its largest new stake was Avantis US Small Cap Value ETF: 22,447 shares worth $1.66M. The largest sale was Jazz Pharmaceuticals, an estimated $2.53M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, up from 90% a quarter earlier, followed by Technology and Financials.
- Callan Capital's largest Q1 2023 buy was Avantis US Small Cap Value ETF: 22,447 shares worth $1.66M.
- Callan Capital added most to Schwab Fundamental US Large Company Index ETF in Q1 2023, an estimated $6.54M increase.
- Callan Capital's biggest Q1 2023 reduction was JPMorgan Ultra-Short Municipal Income ETF, cutting an estimated $2.27M.
- Callan Capital fully exited Jazz Pharmaceuticals in Q1 2023, selling an estimated $2.53M.
- Callan Capital's ten largest holdings make up 51% of its $864M portfolio in Q1 2023.
- Callan Capital opened 11 new positions and closed 13 in Q1 2023.
- Callan Capital's portfolio value rose 6.7% quarter-over-quarter to $864M.
Based on Callan Capital's 13F filing for Q1 2023, filed 9 May 2023.